Success Metrics

Clinical Success Rate

100.0%

Based on 6 completed trials

Completion Rate

100%(6/6)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Phase Distribution

Ph phase_3

50%

Ph phase_4

33%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Phase 3Large-scale testing

3(60.0%)

Phase 4Post-market surveillance

2(40.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(6)

Detailed Status

Completed6

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Phase 33 (60.0%)

Phase 42 (40.0%)

Trials by Status

completed6100%

Recent Activity

0 active trials

Showing 5 of 6

completedphase_3

FOCUS (Nifedipine GITS's Effect on Central Pressure Assessed by Applanation Tonometry)

NCT01071122

completed

Treatment of Hypertension With Adalat® in Combination With Other Drugs

NCT01118286

View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials

NCT01294215Phase 3

High Dose BAYA1040_Nifedipine: a Long Term Combination Study

Completed

NCT01287260Phase 3

High Dose BAYA1040_Nifedipine: a Dose-comparative Study

Completed

NCT01355367Phase 3

High Dose BAYA1040 CR: a Long Term Extension Study

Completed

NCT01071122Phase 4

FOCUS (Nifedipine GITS's Effect on Central Pressure Assessed by Applanation Tonometry)

Completed

NCT01118286

Treatment of Hypertension With Adalat® in Combination With Other Drugs

Completed

NCT01518855Phase 4

Controlled Release Nifedipine and Valsartan Combination Therapy in Patients With Essential Hypertension

Completed

All 6 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 6